SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing significant momentum driven by high trading volume, whale accumulation, and speculation surrounding potential major corporate partnerships. Community sentiment remains highly divided, with many traders riding the volatility of the recent price surge while others express skepticism regarding potential supply releases and the sustainability of the current rally.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is currently seeing significant community activity as investors weigh recent reports of a bank acquisition and ongoing speculation regarding potential institutional partnerships. While some traders are expressing frustration over price volatility and volume, others are actively accumulating based on the project's high-speed blockchain claims and its potential role in future financial infrastructure.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is facing intense volatility as the stock undergoes a sharp correction, triggering heavy debate among traders about whether the current price levels represent a significant buying opportunity or a deeper valuation trap. While some market participants are focused on potential institutional accumulation and long-term infrastructure demand, others are wary of the aggressive insider selling and recent technical breakdowns that have eroded confidence.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending as institutional investors aggressively de-risk from the enterprise SaaS sector, with sentiment pressured by fears that generative AI tools could disrupt traditional workflow management models. Despite persistent selling and fresh 52-week lows, the community remains deeply divided between those viewing the stock as a structurally broken "value trap" and contrarian investors who argue the platform's deep integration and enterprise switching costs provide a durable moat against AI-native competition.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as investors weigh significant manufacturing execution hurdles and yield challenges at its Fab-2 facility against persistent speculation regarding potential strategic partnerships in the AR and smartphone sectors. The community is sharply divided, with intense debate between those betting on a short squeeze or long-term turnaround fueled by proprietary battery tech and those pessimistic about the company's ability to achieve commercial-scale production.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is trending as investors react to a series of strategic milestones, including a new feasibility study for a major Texas power hub and the continued expansion of its microreactor development pipeline. The community is actively debating the company's long-term commercialization timeline and the broader role of advanced nuclear technology in meeting the surging electricity demands of AI data centers.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

IMSR is trending as investors react to the companys dual Other Transaction Agreements with the U.S. Department of Energy, which aim to accelerate the commercialization of its integral molten salt reactor technology. Community discussions are heavily focused on the stock's potential for a significant valuation rerating as it gains federal support, with bulls drawing comparisons to the market trajectory of established sector peers while debating the company's timeline for achieving reactor criticality.

Ares Capital Corp is a traded fund invests in companies located in the United States and Canada with an EBITDA of USD 10 - 250 million. The fund targets companies operating in the fields of health care services, software & services, consumer durables & apparel, energy, food & beverage and retail. It provides financing in the form of debt and equity for mezzanine, buyouts, acquisitions, recapitalizations, restructurings, rescue financing, growth capital and general refinancing with an investment size ranging from USD 10 - 500 million. The fund acquires controlling Interest. It acts as lead investor and takes a seat on the board of directors.

Ares Capital Corp

Ares Capital Corporation

Ares Capital is currently attracting significant attention as investors weigh the stability of its long-standing dividend track record against broader concerns surrounding the private credit sector and potential borrower stress. While some community members view the current share price as a bargain and are actively accumulating shares to capture high yields, others express caution, citing macroeconomic volatility and the risks associated with high exposure to complex loan structures like PIK interest.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape remains in a period of intense retail scrutiny and heavy short-interest, with the community actively debating whether the current price represents a long-term accumulation opportunity ahead of critical manufacturing yield updates. While some investors are frustrated by the lack of frequent PR and the stock's recent price stagnation, others argue that progress on the Eagle production line and potential non-automotive applications represent a coiled spring awaiting a catalyst.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as investors react to mounting legal scrutiny and warnings from CEO Jamie Dimon regarding the risks posed by private credit stress and geopolitical instability. The stock is a focal point for market participants analyzing broader financial health, with activity intensifying as traders monitor its role in major deal-making and potential sensitivity to upcoming interest rate signals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Editas Medicine (NASDAQ:EDIT) Downgraded by Wall Street Zen to Sell

Wall Street Zen cut Editas Medicine from a "hold" rating to a "sell" rating in a report on Saturday...

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Research Weighs in on Editas Medicine FY2028 Earnings

Editas Medicine, Inc. (NASDAQ:EDIT - Free Report) - Analysts at Zacks Research issued their FY2028 earnings estimates for Editas Medicine in a note issued to investors on Monday, March 23rd. Zacks...

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have...

Is Editas Medicine Going to $0?

Key PointsEditas Medicine has been on fire over the trailing-12-month period...

Editas Medicine Details In Vivo CRISPR Plan, Targets Year-End Human Proof-of-Concept for EDIT-401

Editas Medicine (NASDAQ:EDIT) executives outlined the company's in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore...

Editas Medicine (NASDAQ:EDIT) Upgraded at JonesTrading

JonesTrading raised shares of Editas Medicine from a "hold" rating to a "buy" rating and set a $8.00 price objective on the stock in a research note on Tuesday...

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Editas stock jumps 16% on reporting a narrower-than-expected Q4 loss and beating revenue estimates while advancing its EDIT-401 gene-editing candidate toward its first human study in 2026.

Editas Medicine (NASDAQ:EDIT) Receives "Buy" Rating from Chardan Capital

Chardan Capital reiterated a "buy" rating and issued a $3.50 price target on shares of Editas Medicine in a report on Monday...

Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of +77.78% and +280.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.27	--	--	N/A
Q4 '25	-$0.23	-$0.06	74.21%	BEAT
Q3 '25	-$0.30	-$0.28	5.45%	BEAT
Q2 '25	-$0.39	-$0.63	-61.31%	MISSED
Q1 '25	-$0.56	-$0.92	-63.13%	MISSED

EDIT
Editas Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest EDIT News

EDITEditas Medicine Inc